CAV-2 vector development and gene transfer in the central and peripheral nervous systems

The options available for genetic modification of cells of the central nervous system (CNS) have greatly increased in the last decade. The current panoply of viral and nonviral vectors provides multifunctional platforms to deliver expression cassettes to many structures and nuclei. These cassettes c...

Full description

Saved in:
Bibliographic Details
Main Authors: Rio, Danila del, Beucher, Bertrand, Lavigne, Marina, Wehbi, Amani, Dopeso-Reyes, Iria Gonzalez, Saggio, Isabella, Kremer, Eric J.
Other Authors: School of Biological Sciences
Format: Article
Language:English
Published: 2019
Subjects:
Online Access:https://hdl.handle.net/10356/88500
http://hdl.handle.net/10220/49308
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-88500
record_format dspace
spelling sg-ntu-dr.10356-885002023-02-28T17:02:32Z CAV-2 vector development and gene transfer in the central and peripheral nervous systems Rio, Danila del Beucher, Bertrand Lavigne, Marina Wehbi, Amani Dopeso-Reyes, Iria Gonzalez Saggio, Isabella Kremer, Eric J. School of Biological Sciences NTU Institute of Structural Biology Adenovirus CAV-2 Science::Biological sciences The options available for genetic modification of cells of the central nervous system (CNS) have greatly increased in the last decade. The current panoply of viral and nonviral vectors provides multifunctional platforms to deliver expression cassettes to many structures and nuclei. These cassettes can replace defective genes, modify a given pathway perturbed by diseases, or express proteins that can be selectively activated by drugs or light to extinguish or excite neurons. This review focuses on the use of canine adenovirus type 2 (CAV-2) vectors for gene transfer to neurons in the brain, spinal cord, and peripheral nervous system. We discuss (1) recent advances in vector production, (2) why CAV-2 vectors preferentially transduce neurons, (3) the mechanism underlying their widespread distribution via retrograde axonal transport, (4) how CAV-2 vectors have been used to address structure/function, and (5) their therapeutic applications. Published version 2019-07-12T01:17:14Z 2019-12-06T17:04:37Z 2019-07-12T01:17:14Z 2019-12-06T17:04:37Z 2019 Journal Article Rio, D. d., Beucher, B., Lavigne, M., Wehbi, A., Dopeso-Reyes, I. G., Saggio, I., & Kremer, E. J. (2019). CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems. Frontiers in Molecular Neuroscience, 12, 71-. doi:10.3389/fnmol.2019.00071 https://hdl.handle.net/10356/88500 http://hdl.handle.net/10220/49308 10.3389/fnmol.2019.00071 en Frontiers in Molecular Neuroscience © 2019 del Rio, Beucher, Lavigne, Wehbi, Gonzalez Dopeso-Reyes, Saggio and Kremer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. 16 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Adenovirus
CAV-2
Science::Biological sciences
spellingShingle Adenovirus
CAV-2
Science::Biological sciences
Rio, Danila del
Beucher, Bertrand
Lavigne, Marina
Wehbi, Amani
Dopeso-Reyes, Iria Gonzalez
Saggio, Isabella
Kremer, Eric J.
CAV-2 vector development and gene transfer in the central and peripheral nervous systems
description The options available for genetic modification of cells of the central nervous system (CNS) have greatly increased in the last decade. The current panoply of viral and nonviral vectors provides multifunctional platforms to deliver expression cassettes to many structures and nuclei. These cassettes can replace defective genes, modify a given pathway perturbed by diseases, or express proteins that can be selectively activated by drugs or light to extinguish or excite neurons. This review focuses on the use of canine adenovirus type 2 (CAV-2) vectors for gene transfer to neurons in the brain, spinal cord, and peripheral nervous system. We discuss (1) recent advances in vector production, (2) why CAV-2 vectors preferentially transduce neurons, (3) the mechanism underlying their widespread distribution via retrograde axonal transport, (4) how CAV-2 vectors have been used to address structure/function, and (5) their therapeutic applications.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Rio, Danila del
Beucher, Bertrand
Lavigne, Marina
Wehbi, Amani
Dopeso-Reyes, Iria Gonzalez
Saggio, Isabella
Kremer, Eric J.
format Article
author Rio, Danila del
Beucher, Bertrand
Lavigne, Marina
Wehbi, Amani
Dopeso-Reyes, Iria Gonzalez
Saggio, Isabella
Kremer, Eric J.
author_sort Rio, Danila del
title CAV-2 vector development and gene transfer in the central and peripheral nervous systems
title_short CAV-2 vector development and gene transfer in the central and peripheral nervous systems
title_full CAV-2 vector development and gene transfer in the central and peripheral nervous systems
title_fullStr CAV-2 vector development and gene transfer in the central and peripheral nervous systems
title_full_unstemmed CAV-2 vector development and gene transfer in the central and peripheral nervous systems
title_sort cav-2 vector development and gene transfer in the central and peripheral nervous systems
publishDate 2019
url https://hdl.handle.net/10356/88500
http://hdl.handle.net/10220/49308
_version_ 1759853911183720448